Table 3.
Cox hazard regression on association between CD155 expression and prognosis.
| CD155 expression | HRcrude | 95% CI | HR† | 95% CI | HR‡ | 95% CI | ||
|---|---|---|---|---|---|---|---|---|
| Low expression (n = 78) | Overexpression (n = 48) | |||||||
| Disease-free survival, n (%) | ||||||||
| Relapse | 6 (7.7) | 15 (31.3) | 5.41 | 1.93, 15.20 | 5.68 | 2.01, 16.02 | 13.93 | 2.82, 68.91 |
| Survival | 69 (88.5) | 27 (56.3) | ||||||
| Overall survival, n (%) | ||||||||
| Death | 6 (7.7) | 9 (18.8) | 3.74 | 1.25, 11.16 | 4.51 | 1.50, 13.63 | 5.47 | 1.42, 20.99 |
| Survival | 68 (87.2) | 30 (62.5) | ||||||
†Further adjusting age. ‡Further adjusting age, histological grade, and molecular subtype.